Polarean Imaging plc operates as a medical drug-device combination company serving the medical imaging market in the United States and internationally. The company engages in the development and commercialization of gas polarizer devices and ancillary instruments. It develops equipment that enables existing magnetic resonance imaging (MRI) systems to achieve a level of pulmonary functional imaging and specializes in the use of polarized Xenon gas (129Xe) as an imaging agent to visualize ventilation and gas exchange regionally in the smallest airways of the lungs, the tissue barrier between the lung and the bloodstream, and in the pulmonary vasculature; and a novel diagnostic approach. The company also develops and manufactures MRI radiofrequency coils, which are required components for imaging 129Xe in the MRI system. Polarean Imaging plc was incorporated in 2016 and is headquartered in Durham, North Carolina.

Overall MarketRank^™

0.48 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Polarean Imaging.

2.4 Community Rank

Outperform Votes
Polarean Imaging has received 22 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Polarean Imaging has received 23 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Polarean Imaging has received 51.11% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Polarean Imaging and other stocks. Vote “Outperform” if you believe POLX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe POLX will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Polarean Imaging does not currently pay a dividend.
Dividend Growth
Polarean Imaging does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Polarean Imaging insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Polarean Imaging is -27.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Polarean Imaging is -27.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Polarean Imaging has a P/B Ratio of 12.96. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Polarean Imaging (LON:POLX) Frequently Asked Questions

What stocks does MarketBeat like better than Polarean Imaging?

Wall Street analysts have given Polarean Imaging a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Polarean Imaging wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Polarean Imaging's next earnings date?

Polarean Imaging is scheduled to release its next quarterly earnings announcement on Monday, June 14th 2021.
View our earnings forecast for Polarean Imaging.

How has Polarean Imaging's stock been impacted by Coronavirus?

Polarean Imaging's stock was trading at GBX 20.50 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, POLX stock has increased by 348.8% and is now trading at GBX 92.
View which stocks have been most impacted by COVID-19.

Who are Polarean Imaging's key executives?

Polarean Imaging's management team includes the following people:

Mr. Clairis Richard Hullihen, CEO & Director (Age 68, Pay $286.5k)
Dr. Bastiaan Driehuys Ph.D., Founder, CTO & Director (Age 52, Pay $50k)
Mr. Kenneth Paul West, Consultant & Non-Exec. Director (Age 64, Pay $177.05k)
Mr. Charles Fremont Osborne Jr., CFO & Director (Age 55)
Mr. Stephen Austin, Company Sec.

Who are some of Polarean Imaging's key competitors?

Some companies that are related to Polarean Imaging include Drägerwerk AG & Co. KGaA (DRW3), Avacta Group (AVCT), Neuropace (NPCE), Viemed Healthcare (VMD), Asensus Surgical (ASXC), Viemed Healthcare (VMD), Itamar Medical (ITMR), Creo Medical (CREO), Talis Biomedical (TLIS), Titan Medical (TMD), Medica Group (MGP), Hamilton Thorne (HTL), Xtant Medical (XTNT), Advanced Oncotherapy (AVO) and Cannabix Technologies (BLOZF).
View all of POLX's competitors.

What other stocks do shareholders of Polarean Imaging own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Polarean Imaging investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX), Ampio Pharmaceuticals (AMPE), Apellis Pharmaceuticals (APLS), Aquantia (AQ) and Aquinox Pharmaceuticals (AQXP).

What is Polarean Imaging's stock symbol?

Polarean Imaging trades on the London Stock Exchange (LON) under the ticker symbol "POLX."

How do I buy shares of Polarean Imaging?

Shares of POLX and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Polarean Imaging's stock price today?

One share of POLX stock can currently be purchased for approximately GBX 92.

How much money does Polarean Imaging make?

Polarean Imaging has a market capitalization of £192.31 million and generates £2.23 million in revenue each year.

How many employees does Polarean Imaging have?

Polarean Imaging employs 19 workers across the globe.

What is Polarean Imaging's official website?

The official website for Polarean Imaging is www.polarean.com.

How can I contact Polarean Imaging?

The company can be reached via phone at 919 206 7900.

This page was last updated on 5/7/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Polarean Imaging Share Forecast, Price & News

Adding

Adding

Adding Polarean Imaging plc

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Headlines

About Polarean Imaging

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

Consensus Rating

2.4 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment

0.0 Dividend Strength

Dividend Yield

Dividend Growth

0.0 Company Ownership

Insider Buying vs. Insider Selling

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market

Price to Earnings Ratio vs. Sector

Price to Book Value per Share Ratio